Info
Insider Ownership

Insider Trading & Ownership of Dimitris Voliotis

Location: New York, NY
Summary: The estimated net worth of Dimitris Voliotis is at least $1.32M dollars as of 14 Feb 2022. Dimitris Voliotis is the SVP, Clinical Development of Zentalis Pharmaceuticals, Inc. and owns shares of Zentalis Pharmaceuticals, Inc. (ZNTL) stock worth about $1.32M.
Signature: /s/ Melissa B. Epperly, Attorney-in-Fact for Dimitris Voliotis
All Insider Reports: All Insider Reports

Notify me when Dimitris Voliotis files a new Insider Trading report.

⭐ Subscribe ⭐

Ownership of Dimitris Voliotis

Symbol	Company	Relationship	Holdings Value	Past Year Net Change	Change %	Report Period
ZNTL	Zentalis Pharmaceuticals, Inc.	SVP, Clinical Development	$1.32M			10 Feb 2022

Insider Transactions Reported by Dimitris Voliotis:

Sym	Company	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.